- Anglo American: RBC upgrades from Outperform to Sector Perform with a target of GBp3,400.
- AstraZeneca: Berenberg advises its customers to buy the stock. The target price is still set at GBp 95.
- Auto Trader: Berenberg remains Hold with a price target raised from GBp 520 to GBp 650.
- Biogen : JPMorgan adjusts pt to $435 from $269, maintains neutral rating
- GlaxoSmithKline: Berenberg is positive on the stock with a Buy rating. The target price is still set at GBp 1570.
- ITM Power: RBC starts tracking at sector perform, targeting GBp 310.
- John Laing: HSBC upgraded from buy to hold, targeting GBP 403.
- Pagegroup: Morgan Stanley upgraded from Overweight to Underweight, targeting GBP 545.
- Pfizer: Berenberg is keeping its Neutral rating. The target price is unchanged at USD 43.
- Procore Technologies : Oppenheimer initiates coverage with outperform rating, $100 price target
- RAPT Therapeutics : Cantor Fitzgerald hikes pt to $71 from $51 atopic dermatitis treatment results, keeps overweight rating
- Rolls-Royce: Berenberg still considers the stock as a Buy opportunity. The target price is unchanged and still at GBp 150.
- Nike: UBS retains his positive opinion on the stock with a Buy rating. The target price is set at USD 170 versus USD 175.
- Oatly : Barclays initiates at overweight rating with $34 price target
- The Boeing Company: Berenberg's research confirms its neutral opinion on the stock. The target price has been raised from USD 215 to USD 245.
- United Airlines : Citigroup adjusts price target to $67 from $65, keeps buy rating